Black Diamond Therapeutics (BDTX) Total Liabilities: 2018-2020

Historic Total Liabilities for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $21.9 million.

  • Black Diamond Therapeutics' Total Liabilities rose 189.04% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 189.04%. This contributed to the annual value of $21.9 million for FY2020, which is 349.11% up from last year.
  • Black Diamond Therapeutics' Total Liabilities amounted to $21.9 million in FY2020, which was up 349.11% from $4.9 million recorded in FY2019.
  • Black Diamond Therapeutics' 5-year Total Liabilities high stood at $21.9 million for FY2020, and its period low was $4.9 million during FY2019.
  • In the last 3 years, Black Diamond Therapeutics' Total Liabilities had a median value of $6.6 million in 2018 and averaged $11.1 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first dropped by 26.05% in 2019, then spiked by 349.11% in 2020.
  • Over the past 3 years, Black Diamond Therapeutics' Total Liabilities (Yearly) stood at $6.6 million in 2018, then dropped by 26.05% to $4.9 million in 2019, then spiked by 349.11% to $21.9 million in 2020.